HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryuya Iwamoto Selected Research

acetylleucyl-leucyl-norleucinal

6/2012Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin-secreting capacity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryuya Iwamoto Research Topics

Disease

3Insulin Resistance
11/2017 - 06/2012
2Type 2 Diabetes Mellitus (MODY)
07/2018 - 06/2012
2Hyperinsulinism (Hyperinsulinemia)
11/2017 - 01/2015
2Neoplasms (Cancer)
01/2010 - 01/2009
1Donohue Syndrome
11/2017
1Insulinoma
01/2015
1Hypoglycemia (Reactive Hypoglycemia)
01/2015
1Gastrinoma
01/2010
1Multiple Endocrine Neoplasia Type 1
01/2010
1Adenoma (Adenomas)
01/2009

Drug/Important Bio-Agent (IBA)

3Insulin (Novolin)FDA Link
11/2017 - 06/2012
2Insulin ReceptorIBA
11/2017 - 01/2015
1AdiponectinIBA
07/2018
1AutoantibodiesIBA
01/2015
1Glucose (Dextrose)FDA LinkGeneric
01/2015
1Nonsense Codon (Nonsense Mutation)IBA
01/2015
1acetylleucyl-leucyl-norleucinalIBA
06/2012
1LiraglutideFDA Link
06/2012
1cyclopropapyrroloindoleIBA
06/2012
1Octreotide (Sandostatin)FDA LinkGeneric
01/2010
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2010
1somatostatin receptor 2IBA
01/2010
1Parathyroid Hormone-Related ProteinIBA
01/2009
1CalciumIBA
01/2009
1Monoclonal AntibodiesIBA
01/2009

Therapy/Procedure

1Glycemic Control
06/2012
1Cardiopulmonary Resuscitation (CPR)
06/2012